Pancreatic Diseases clinical trials at UC Health
2 in progress, 1 open to eligible people
A Study of Experimental Cefoxitin or Piperacillin-Tazobactam to Prevent Postoperative Infections After Pancreatic Cancer Surgery
“This study hopes to determine whether Cefoxitin or Piperacillin-Tazobactam prevents postoperative infections better.”
open to eligible people ages 18 years and up
The purpose of this study is to figure out which commonly used antibiotic, cefoxitin or piperacillin-tazobactam, is better at decreasing the rate of surgical site infections after pancreatoduodenectomy.
at UC Davis
Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)
Sorry, in progress, not accepting new patients
The purpose of this study is to compare whether there is a delay or prevention of recurrence or death in subjects with surgically removed pancreatic cancer who then take nab-paclitaxel in combination with gemcitabine compared to those who take gemcitabine alone.
at UCSF UCSD UC Davis UCLA